A Randomized, Parallel-Group, Open Label, Multicenter Study to Evaluate the Effects of Tocilizumab on Vaccination in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate.

Trial Profile

A Randomized, Parallel-Group, Open Label, Multicenter Study to Evaluate the Effects of Tocilizumab on Vaccination in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate.

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Jun 2015

At a glance

  • Drugs Tocilizumab (Primary) ; Methotrexate; Pneumococcal vaccine; Pneumococcal vaccine; Tetanus vaccine
  • Indications Pneumococcal infections; Rheumatoid arthritis; Tetanus
  • Focus Pharmacodynamics
  • Acronyms VISARA
  • Sponsors Genentech
  • Most Recent Events

    • 14 Nov 2012 Results presented at the 76th Annual Scientific Meeting of the American College of Rheumatology and the 47th Annual Meeting of the Association of Rheumatology and Health Professionals.
    • 07 Feb 2012 Actual patient number (86) added as reported by ClinicalTrials.gov.
    • 07 Feb 2012 Planned end date changed from 1 Jan 2012 to 1 Aug 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top